A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer

Name: A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer
License: Public Domain

Tianjin Medical University Cancer Institute and Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

colorectalcancer

braf v600e, colorectal cancer, sintilimab, mss (microsatellite stable), cetuximab, dabrafenib

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 279522
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.